Transient shrinkage of a uterine leiomyosarcoma treated with GnRH agonist for a presumed uterine leiomyoma: Comparison of magnetic resonance imaging finding before and during GnRH agonist treatment

Oncology Reports

Volumn 8, Issue 6, 2001, Pages 1255-1257

  Kawamura, Naoki ^a   Iwanaga, Naoko ^a   Hada, Sachiko ^a   Maeda, Kyoko ^a   Sumi, Toshiyuki ^a   Ishiko, Osamu ^a   Ogita, Sachio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

GnRH agonist; Leiomyosarcoma; MRI; Needle biopsy

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BUSERELIN;

ARTICLE; CASE REPORT; FEMALE; HUMAN; LEIOMYOMA; LEIOMYOSARCOMA; MIDDLE AGED; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREMENOPAUSE; UTERUS CANCER;

ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY, NEEDLE; BUSERELIN; FEMALE; HUMANS; LEIOMYOMA; LEIOMYOSARCOMA; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PREMENOPAUSE; UTERINE NEOPLASMS;

EID: 0035514232     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.6.1255     Document Type: Article

References (8)

1. Fujii S (ed): An Atlas of MRI with Histopathology on Smooth Muscle Tumors of the Uterus. Medical View, Tokyo, 1999.
2. Kawamura N, Shibata S, Ito F, Ichimura T, Umesaki N and Ogita S: Practical method for transcervical needle biopsy of uterine leiomyomas to avoid unnecessary surgery. J Gynecol Tech 2: 201-206, 1996.
3. Friedman AJ, Lobel SM, Rein MS and Barbieri RL: Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis. Am J Obstet Gynecol 163: 1114-1119, 1990.
4. Murphy NJ and Wallace DL: Gonadotropin releasing hormone (GnRH) agonist therapy for reduction of leiomyoma volume. Gynecol Oncol 49: 266-267, 1993.
5. Milman D, Zalel Y, Biran H, et al: Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: a case report and literature review. Eur J Obstet Gynecol Reprod Biol 76: 237-240, 1998.
6. Zhai YL, Kobayashi Y, Mori A, et al: Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 18: 20-28, 1999.
7. Ito F, Kawamura N, Ichimura T, Tsujimura A, Ishiko O and Ogita S: Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment. Fertil Steril 75: 125-130, 2001.
8. Matta WH, Stabile I, Shaw RW and Campbell S: Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin. Fertil Steril 49: 1083-1085, 1988.